Business · 21/09/2023
FDA Hosts Public Workshop on Menopause Impact on Clinical Pharmacology
The FDA is hosting a public workshop to discuss the impact of menopause on FDA-regulated drugs and biologics, with a focus on potential research gaps and areas for future study.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →